AdvaMed Pleads Its Case on Medical Device Tariffs
AdvaMed wants to collaborate with the Trump administration to recognize and reward the unique strength of the U.S. medtech industry.
AdvaMed President and CEO Scott Whitaker said his group wants to work with the Trump administration “to recognize and to reward the unique strength of the U.S. medtech industry” with supportive policies.
AdvaMed submitted comments to Commerce Secretary, offering an overview of the domestic medtech industry, including recent investments, employment growth, and R&D spending driving medical innovation.
- Seeking fair and reciprocal tariff-free trade with key allies
- Addressing unfair market access barriers in specific countries
- Advancing domestic regulatory reforms and procurement incentives to enhance U.S. competitiveness
Author's summary: AdvaMed seeks support for the U.S. medtech industry.